PAS
NVAX icon

Point72 Asia (Singapore)’s Novavax NVAX Stock Holding History

Point72 Asia (Singapore)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$65.3K Sell
7,533
-3,783
-33% -$29.4K 0.01% 520
2025
Q2 		$71.3K Buy
+11,316
New +$74.9K 0.01% 533

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asia (Singapore)'s NVAX Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Novavax (NVAX) stake by 33% in Q3 2025, selling an estimated $29.4K and leaving 7,533 shares worth $65.3K. The position accounts for 0.01% of the portfolio, ranked #520.

Point72 Asia (Singapore) first reported a position in NVAX in Q2 2025 and has held it in 2 quarters since. The position peaked at $71.3K in Q2 2025. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Point72 Asia (Singapore) held 7,533 shares of Novavax worth $65.3K as of Q3 2025.
  • Point72 Asia (Singapore) sold 3,783 Novavax shares in Q3 2025, an estimated $29.4K.
  • Novavax made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #520 holding.
  • Point72 Asia (Singapore) first reported a position in Novavax in Q2 2025 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Novavax position peaked at $71.3K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.